AxoGen (LT3) Financial Statements
AxoGen Financial Overview
AxoGen's market cap is currently $2.64B. The company's EPS TTM is $-0.65; its P/E ratio is -75.95; AxoGen is estimated to report earnings on February 23, 2027, and the estimated EPS forecast is $0.13. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 225.21M | $ 187.34M | $ 159.01M | $ 138.58M | $ 127.36M |
| Gross Profit | $ 167.35M | $ 141.98M | $ 121.87M | $ 108.81M | $ 104.43M |
| Operating Income | $ -7.85M | $ -3.29M | $ -21.46M | $ -29.71M | $ -25.42M |
| EBITDA | $ 192.00K | $ 6.08M | $ -13.33M | $ -23.47M | $ -20.89M |
| Net Income | $ -15.70M | $ -9.96M | $ -21.72M | $ -28.95M | $ -26.98M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 35.55M | $ 33.48M | $ 31.02M | $ 48.79M | $ 84.09M |
| Total Assets | $ 221.69M | $ 203.73M | $ 196.83M | $ 195.39M | $ 208.02M |
| Total Debt | $ 67.63M | $ 68.69M | $ 69.29M | $ 67.43M | $ 67.45M |
| Net Debt | $ 32.08M | $ 41.13M | $ 38.27M | $ 52.14M | $ 34.70M |
| Total Liabilities | $ 92.84M | $ 99.82M | $ 101.16M | $ 94.39M | $ 95.47M |
| Stockholders' Equity | $ 128.85M | $ 103.91M | $ 95.67M | $ 101.00M | $ 112.55M |
| Cash Flow | |||||
| Free Cash Flow | $ -2.93M | $ 11.00K | $ -20.63M | $ -37.32M | $ -41.80M |
| Operating Cash Flow | $ 812.00K | $ 4.54M | $ -5.72M | $ -16.07M | $ -13.40M |
| Investing Cash Flow | $ -5.32M | $ -10.30M | $ 19.25M | $ -3.20M | $ -23.65M |
| Financing Cash Flow | $ 10.50M | $ 2.29M | $ 1.95M | $ 1.79M | $ 20.45M |
Currency in USD
